Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

There is no significant link between metabolic syndrome and alopecia areata.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Human hair contains many different molecules that change along its length, influenced by personal care products.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Skin enzymes convert topical drugs into active forms, affecting drug effectiveness and safety.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.